195 related articles for article (PubMed ID: 25473752)
1. Pax2 expression in simultaneously diagnosed WHO and EIN classification systems.
Joiner AK; Quick CM; Jeffus SK
Int J Gynecol Pathol; 2015 Jan; 34(1):40-6. PubMed ID: 25473752
[TBL] [Abstract][Full Text] [Related]
2. Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia.
Quick CM; Laury AR; Monte NM; Mutter GL
Am J Clin Pathol; 2012 Nov; 138(5):678-84. PubMed ID: 23086768
[TBL] [Abstract][Full Text] [Related]
3. Endometrial Intraepithelial Neoplasia (EIN) in endometrial biopsy specimens categorized by the 1994 World Health Organization classification for endometrial hyperplasia.
Li XC; Song WJ
Asian Pac J Cancer Prev; 2013; 14(10):5935-9. PubMed ID: 24289604
[TBL] [Abstract][Full Text] [Related]
4. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
[TBL] [Abstract][Full Text] [Related]
5. BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia.
Trabzonlu L; Muezzinoglu B; Corakci A
Pathol Oncol Res; 2019 Apr; 25(2):471-476. PubMed ID: 29270778
[TBL] [Abstract][Full Text] [Related]
6. PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.
Raffone A; Travaglino A; Saccone G; Mascolo M; Insabato L; Mollo A; De Placido G; Zullo F
Acta Obstet Gynecol Scand; 2019 Mar; 98(3):287-299. PubMed ID: 30511741
[TBL] [Abstract][Full Text] [Related]
7. Reliable Identification of Endometrial Precancers Through Combined Pax2, β-Catenin, and Pten Immunohistochemistry.
Aguilar M; Chen H; Rivera-Colon G; Niu S; Carrick K; Gwin K; Cuevas IC; Sahoo SS; Li HD; Zhang S; Zheng W; Lucas E; Castrillon DH
Am J Surg Pathol; 2022 Mar; 46(3):404-414. PubMed ID: 34545858
[TBL] [Abstract][Full Text] [Related]
8. PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia.
Allison KH; Upson K; Reed SD; Jordan CD; Newton KM; Doherty J; Swisher EM; Garcia RL
Int J Gynecol Pathol; 2012 Mar; 31(2):151-159. PubMed ID: 22317873
[TBL] [Abstract][Full Text] [Related]
9. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system.
Baak JP; Mutter GL; Robboy S; van Diest PJ; Uyterlinde AM; Orbo A; Palazzo J; Fiane B; Løvslett K; Burger C; Voorhorst F; Verheijen RH
Cancer; 2005 Jun; 103(11):2304-12. PubMed ID: 15856484
[TBL] [Abstract][Full Text] [Related]
10. Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps.
Lucas E; Niu S; Aguilar M; Molberg K; Carrick K; Rivera-Colon G; Gwin K; Wang Y; Zheng W; Castrillon DH; Chen H
Am J Surg Pathol; 2023 Sep; 47(9):1019-1026. PubMed ID: 37314146
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women.
Norimatsu Y; Moriya T; Kobayashi TK; Sakurai T; Shimizu K; Tsukayama C; Ohno E
Ann Diagn Pathol; 2007 Apr; 11(2):103-8. PubMed ID: 17349568
[TBL] [Abstract][Full Text] [Related]
12. Endometrial intraepithelial neoplasia.
Owings RA; Quick CM
Arch Pathol Lab Med; 2014 Apr; 138(4):484-91. PubMed ID: 24678678
[TBL] [Abstract][Full Text] [Related]
13. International Internet-based assessment of observer variability for diagnostically challenging endometrial biopsies.
Marotti JD; Glatz K; Parkash V; Hecht JL
Arch Pathol Lab Med; 2011 Apr; 135(4):464-70. PubMed ID: 21466363
[TBL] [Abstract][Full Text] [Related]
14. [The premalignant disease of the endometrium: endometrial intraepithelial neoplasia].
Francz M
Magy Onkol; 2008 Mar; 52(1):35-40. PubMed ID: 18403295
[TBL] [Abstract][Full Text] [Related]
15. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group.
Mutter GL
Gynecol Oncol; 2000 Mar; 76(3):287-90. PubMed ID: 10684697
[TBL] [Abstract][Full Text] [Related]
16. PI3K Pathway Effectors pAKT and FOXO1 as Novel Markers of Endometrioid Intraepithelial Neoplasia.
Strickland AL; Rivera G; Lucas E; John G; Cuevas I; Castrillon DH
Int J Gynecol Pathol; 2019 Nov; 38(6):503-513. PubMed ID: 30256235
[TBL] [Abstract][Full Text] [Related]
17. Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis.
Rewcastle E; Varhaugvik AE; Gudlaugsson E; Steinbakk A; Skaland I; van Diermen B; Baak JP; Janssen EAM
Endocr Relat Cancer; 2018 Dec; 25(12):981-991. PubMed ID: 30400021
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification.
Ordi J; Bergeron C; Hardisson D; McCluggage WG; Hollema H; Felix A; Soslow RA; Oliva E; Tavassoli FA; Alvarado-Cabrero I; Wells M; Nogales FF
Histopathology; 2014 Jan; 64(2):284-92. PubMed ID: 24111732
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of PAX2 in hyperplastic and malignant endometrium.
Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F
Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645
[TBL] [Abstract][Full Text] [Related]
20. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis.
Hecht JL; Ince TA; Baak JP; Baker HE; Ogden MW; Mutter GL
Mod Pathol; 2005 Mar; 18(3):324-30. PubMed ID: 15529181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
